Johannesburg – March 2022 - Cerba Lancet Africa, the leading clinical pathology and medical diagnosis network in Africa, officially opened its new headquarter at 44 Stanley Studio, Milpark, Johannesburg. This is a major milestone for Cerba Lancet Africa, as the team is continuously growing and the move provides a much better workspace, as well as being more spacious and modern.

The new offices will also allow Cerba Lancet Africa to fulfil its ambitious growth plans for Africa and the commitment to delivering high-quality, cost-effective diagnosis services. To this end, the team will focus on developing a customer-centric culture, improved operational efficiencies and continually investing in employees, with the help of the new ERP system. “We are improving on our entire ecosystem to allow our teams to generate high-quality diagnostics and guide medical decision-making that will better serve our end customers” stated Matthieu Gogué, Corporate General Manager & COO, Cerba Lancet Africa.

Cerba Lancet Africa is gearing up to add value to its African business partners by building a dedicated team. Key supporting and back-office functions, such as HR, supply chain, IT, finance, and marketing are laying the groundwork to standardise and align processes and improve workflow and communications within the entire network.

Cerba Lancet Africa will also consolidate its service offerings by launching this year two strategic divisions; radiology which will reinforce its leading diagnostics service provider position, and a Corporate Health Services division, which will offer a full suite of medical services to businesses across a wide range of industries.

“The new structure should allow Cerba Lancet Africa to better serve our increasing number of customers across the African continent. They can count on the support and the engagement of its shareholders, Cerba Lancet Africa and Lancet Laboratories, to assist in the delivery of the long-term and sustainable strategy” commented Jérôme Thill, Deputy Chief Executive Officer of Cerba HealthCare.

Stephane Carré, VP International and CEO Cerba Lancet Africa, who frequently visited the team since the creation of the Joint Venture in 2019, commended them for “being part of such an incredible journey and having achieved so much in such a short time. Their enthusiasm combined with the potential of the new organization is a winning recipe for our growth across the African continent”.

About CERBA LANCET AFRICA

Cerba Lancet Africa is the leading network of clinical pathology and medical diagnosis in Africa, with the ambition to become the leading diagnostic services provider in Africa, bringing world-class standards of pathology services to patients and medical communities across the continent.

Cerba Lancet Africa is a joint venture created in 2019 with the French group Cerba HealthCare, a leading international player in medical diagnosis, and Lancet Laboratories, the foremost name in clinical pathology in sub-Saharan Africa.